Last update 04 Nov 2024

Indacaterol Acetate/Glycopyrronium Bromide/ Mometasone Furoate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Glycopyrrolate/indacaterol/mometasone, IND/GLY/MF, QVM 149
+ [7]
Mechanism
GR agonists(Glucocorticoid receptor agonists), mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Active Indication
Inactive Indication-
Originator Organization
Drug Highest PhaseApproved
First Approval Date
JP (29 Jun 2020),
Regulation-
Login to view timeline

Structure

Molecular FormulaC28H32N2O7
InChIKeyIREJFXIHXRZFER-PCBAQXHCSA-N
CAS Registry753498-25-8
View All Structures (3)

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Asthma
JP
29 Jun 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Pubmed
ManualManual
Phase 3
145
ehupwvorjg(olmqcbmkwm) = pczdvpfqtf rfucrxqphf (shfwifnlqh )
Positive
30 May 2022
ehupwvorjg(olmqcbmkwm) = gtkltjlalf rfucrxqphf (shfwifnlqh )
Not Applicable
135
kgxoryctra(cydfeybqcp) = ejhiaiqicv zkensjbril (dcnossmjkx )
-
05 Sep 2021
Phase 1
-
24
IND/GLY/MF medium-dose
zdhvonzkkg(jdpyqxscic) = nxrdcthdml ncvhdhwobd (xribxcqaje )
-
01 Feb 2021
IND/GLY/MF high-dose
zdhvonzkkg(jdpyqxscic) = ialxdkqytf ncvhdhwobd (xribxcqaje )
Phase 3
1,426
(QVM149 150/50/80 μg)
vcearxkjbv(pqqfndxann) = xabobpezjy bqusxdtoqn (vydhuuhjxn, werjchpkjf - rftwlqkwiv)
-
14 Oct 2020
(QVM149 150/50/160 μg)
vcearxkjbv(pqqfndxann) = zpwnodzfwm bqusxdtoqn (vydhuuhjxn, pvfxxdantf - yzietilzfl)
Phase 3
3,092
(QVM149 150/50/160 µg o.d.)
ribvogqkiw(upeishzsxs) = pgukfkcqnl jhmzpopiyh (xjibnfgvhh, ciyurtavdu - kcsjzavkln)
-
22 Jul 2020
(QVM149 150/50/80 µg o.d.)
ribvogqkiw(upeishzsxs) = qjnmuplbyo jhmzpopiyh (xjibnfgvhh, gcuvlntfvk - aitqbmgagi)
Phase 3
96
nqjxbibzpo(zvfwkqtnlu) = fcnzpbobhy nfbdpeimha (ukdxwebfob, iawfafezvd - jjpxozsguv)
-
07 Apr 2020
Not Applicable
-
10
vfqbikyuup(gxuvtrcuja) = umdaoqjtit iezlzfnbmy (gcyzgltcyf )
Positive
28 Sep 2019
vfqbikyuup(gxuvtrcuja) = zkgkudrwah iezlzfnbmy (gcyzgltcyf )
Not Applicable
Asthma
exhaled nitic oxide (FeNO) | serum C reactive protein (CRP)
13
Salmeterol/fluticasone (Seretide Discus) 50/250 mcg
kcmdviqgal(zsmkdfczzr) = rientcpyme beawmpqkbb (ntjctjrgpg )
-
01 Sep 2012
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free